“…A large number of literature reports indicated that there was a deterministic relation between higher CRP level, change in brain structure, and depression (D'Mello & Swain, 2017; Felger et al., 2020; Kelly et al., 2019; Ng et al., 2018; Vulser et al., 2015), still the relationship between peripheral inflammation, brain structure, and depression remains unclear. A recent work showed that DNA methylation of CRP was significantly associated with reduced global gray matter/cortical volume and widespread reductions in integrity of 16/24 white matter tracts, the methylation‐based measures showed stronger associations with imaging metrics than serum‐based CRP measures, and these findings provide evidence for central effects of peripheral inflammation from both serological and epigenetic markers of inflammation, including in brain regions previously implicated in depression (Green et al., 2020). A review demonstrated that the early life adversity–perinatal depressive risk model, as we have proposed, invokes epigenetic embedding as a key pathway that promotes a pro‐inflammatory phenotype (higher levels of pro‐inflammatory cytokines and lower levels of oxytocin), which, in turn, shapes maternal stress reactivity, mood, and behavior (Garfield et al., 2015).…”